BVMF/R2AR34 (BVMF/R2AR34)

Brazil Stock Exchange: BVMF/R2AR34 · BRL

R$9.23

+0.39 (+4.4%)· Recorded snapshot

Market cap	9.1B
Revenue (ttm)	3.7B
Net income (ttm)	-3B
EPS (ttm)	-R$3.12
Volume	1,531

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3.7B
Net income (ttm): -3B
EPS (ttm): -R$3.12
Market cap: 9.1B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 11.9P50 16.6P75 25.6

Trailing P/En/a

P25 15.1P50 22.9P75 38.5

ROEn/a

P25 2.7P50 10.8P75 20.1

ROIC-31.8

P25 6.3P50 12.1P75 21.3

Benchmarks · 1M

All BVMF/R2AR34 indicators

Market & fundamental data

Available fields

165

Groups with data

Currency

USD

Showing 165 of 165 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-11-03
Employees	1,371
Employees change	77
Employees growth	5.95%
Enterprise value	BRL 13.2B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-07-12
Fiscal year end	December
Founded	2010
Industry	Biotechnology
Is primary listing	No
ISIN number	BRR2ARBDR006
Last earnings date	2026-08-04
Last refreshed	2026-10-29
Market cap	BRL 9.1B
Next earnings date	2026-11-03
Price	BRL 9.23
Price currency	BRL
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	bvmf/R2AR34
Website	https://www.ultragenyx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-33.75%
EV/Sales	3.44x
FCF / EV yield	-19.14%
FCF yield	-27.89%
P/S ratio	2.45x
Sector forward P/E	11.07x
Sector P/E	40.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-69.46%
EBITDA margin	-64.85%
Gross margin	-20.78%
Operating margin	-69.46%
Pretax margin	-81.17%
Profit margin	-81.73%
Profit per employee	BRL -2.2M
Revenue per employee	BRL 2.7M
ROA	-24.22%
ROA (5Y)	-21.76%
ROCE	-54.55%
ROE (5Y)	-233.65%
ROIC	-31.77%
SBC / revenue	19.39%
Tax / revenue	0.56%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	3
Net income growth quarters	1
Net income growth years	0
Revenue growth	17.51%
Revenue growth (Q)	28.14%
Revenue growth (QoQ)	57.35%
Revenue growth 10Y	190.07%
Revenue growth 3Y	21.19%
Revenue growth 5Y	14.81%
Revenue growth quarters	1
Revenue growth years	9

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -20.7M
Depreciation and amortization	BRL 176.4M
EBIT	BRL -2.6B
EBITDA	BRL -2.4B
EPS	BRL -3.12
Financing cash flow	BRL 2.1B
Free cash flow	BRL -2.5B
Free cash flow minus SBC	BRL -3.3B
Gross profit	BRL -771.9M
Income taxes	BRL 20.7M
Investing cash flow	BRL 207.2M
Net cash flow	BRL -253.9M
Net income	BRL -3B
Operating cash flow minus SBC	BRL -3.2B
Operating income	BRL -2.6B
Revenue	BRL 3.7B
Stock-based compensation	BRL 720.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-4.78
Book value per share	BRL -15.34
Goodwill	BRL 235.2M
Interest coverage	-6.47
Long-term assets	BRL 3.3B
Long-term liabilities	BRL 6.1B
Net cash (debt)	BRL -4B
Net cash / market cap	-43.69%
Piotroski F-Score	3
Property, plant and equipment	BRL 1.3B
Shareholders' equity	BRL -1.5B
Tangible book value	BRL -2.6B
Tangible book value per share	BRL -26.72
Total assets	BRL 6.5B
Total cash	BRL 1.5B
Total debt	BRL 6.2B
Total liabilities	BRL 8B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.56
Current assets	BRL 3.2B
Current liabilities	BRL 1.9B
Current ratio	1.73
Inventory turnover	16.42
Net working capital	BRL 202.1M
Quick ratio	1.41
Working capital	BRL 1.3B
Working capital turnover	10.9

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-4.22%
Shareholder yield	-4.22%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 20.41
1D price change	4.41%
1M price change	24.73%
1M total return	24.73%
1W price change	25.92%
1W total return	25.92%
1Y price change	-49.51%
1Y return CAGR	-49.53%
1Y total return	-49.51%
20-day SMA	BRL 7.74
3M price change	-42.17%
3M total return	-42.17%
3Y price change	-41.51%
3Y return CAGR	-16.37%
3Y total return	-41.51%
50-day SMA	BRL 10.17
52-week high	BRL 20.90
52-week high date	2025-12-15
52-week low	BRL 6.68
52-week low date	2026-09-16
6M price change	-22.63%
6M total return	-22.63%
All-time high	BRL 39.36
All-time high date	2022-04-06
All-time low	BRL 6.68
All-time low date	2026-09-15
Average true range (ATR)	BRL 0.44
Average volume	273.4
Change from 52-week high	-55.84%
Change from 52-week low	38.17%
Change from all-time high	-76.55%
Change from all-time low	38.17%
Change from open	6.58%
Day's gap	-2.04%
Dollar volume	BRL 14,131
High price	BRL 9.26
Low price	BRL 8.66
Monthly RSI	39.36
Open price	BRL 8.66
Position in 52-week range	95%
Previous close	BRL 8.84
Price vs 150-day SMA	-54.78%
Price vs 20-day SMA	19.24%
Price vs 50-day SMA	-9.26%
Relative volume	5.6
RSI	58.24
Sharpe ratio	-0.63
Sortino ratio	-0.8
Volume	1.5K
Weekly RSI	34.71
YTD price change	-55.84%
YTD total return	-55.84%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	74.1M
Shares change (QoQ)	1.29%
Shares change (YoY)	4.22%
Shares held by insiders	3.61%
Shares held by institutions	96.92%
Short ratio	4.8 days

Deeper analysis on BVMF/R2AR34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/R2AR34 report

Is a complete BVMF/R2AR34 research report available?

No complete published report is available for bvmf/R2AR34 (BVMF/R2AR34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/R2AR34 (BVMF/R2AR34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/R2AR34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/R2AR34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/R2AR34

Frequently asked questions